Abstract
The recent French observation that daily tobacco smokers have a substantially reduced risk of developing symptomatic infection with covid‐19 [1] is intriguing, since no health care professional would recommend smoking. So, what are the mechanisms and could something else be at play than tobacco smoking?
Originalsprog | Engelsk |
---|---|
Tidsskrift | APMIS - Journal of Pathology, Microbiology and Immunology |
Vol/bind | 128 |
Udgave nummer | 10 |
Sider (fra-til) | 558 |
Antal sider | 559 |
ISSN | 0903-4641 |
DOI | |
Status | Udgivet - okt. 2020 |